The additional 3% weight loss Retatrutide achieves over Tirzepatide reflects the contribution of glucagon pathway activation
Microdosing GLP-1s has quietly entered the medical conversation at a time when many patients want to use it for weight loss and to maintain the benefits theyve achieved
For most GLP-1 users, it is not
Seiwerth, S., Milavic, M., Vukojevic, J., Gojkovic, S., Krezic, I., Batelja Vuletic, L., Horvat Pavlov, K., Petrovic, A., Sikiric, S., Vranes, H., Prtoric, A., Zizek, H., Durasin, T., Dobric, I., Staresinic, M., Strbe, S., Knezevic, M., Sola, M., Kokot, A., Sever, M., Lovric, E., Skrtic, A., Boban Blagaic, A., & Sikiric, P
This action increases insulin secretion when blood glucose levels go up